Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment

Giorgio Battaglia, Silvia Pagliardini, Laura Saglietti, Flaminio Cattabenil, Monica Di Luca, Stefania Bassanini, Veronica Setola

Research output: Contribution to journalArticlepeer-review


We have previously demonstrated that the antiproliferative agent methylazoxymethanol acetate (MAM) is able to induce in rats cerebral heterotopia that share striking similarities with those observed in human periventricular nodular heterotopia (PNH), a cerebral dysgenesis frequently observed in human patients affected by drug-resistant focal epilepsy. In this study, we investigated the time-course of neurogenesis in the cerebral heterotopia of MAM-treated rats, with the idea of understanding why PNH develop in human patients. For these goals, we analyzed the cytoarchitectural features, the time of neurogenesis and the cellular phenotype of the heterotopia, by means of BrdU immunocytochemistry and confocal immunofluorescence experiments. Our data demonstrate that the different types of heterotopia in MAM-treated rats are formed through the same altered neurogenetic process, which follows quite organized neurogenetic gradients. The MAM-induced ablation of an early wave of cortical neurons is sufficient to alter per se the migration and differentiation of subsequently generated neurons, which in turn set the base for the formation of the different heterotopic structures. The neurogenesis of MAM-induced heterotopia may explain the origin and intrinsic epileptogenicity of periventricular nodular heterotopia in human patients.

Original languageEnglish
Pages (from-to)736-748
Number of pages13
JournalCerebral Cortex
Issue number7
Publication statusPublished - Jul 1 2003

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment'. Together they form a unique fingerprint.

Cite this